Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van bedrijfsleiders
Portrait de Robert Alexander Ingram
Leeftijd : 78
Vermogen : 1 447 342 USD
Belangrijkste bedrijven : BioCryst Pharmaceuticals, Inc. - Black Diamond Therapeutics, Inc.
Overzicht 
Robert Alexander Ingram is an American businessperson who founded CEO Roundtable on Cancer, Inc. and who has been at the head of 21 different companies. Mr. Ingram is Chairman for BioCryst Pharmaceuticals, Inc., Chairman at Viamet Pharmaceuticals Corp., Chairman for Viamet Pharmaceuticals, Inc. (a subsidiary of Viamet Pharmaceuticals Corp.), Chairman at Research Triangle Foundation, Chairman at Black Diamond Therapeutics, Inc. and General Partner for Hatteras Venture Partners. Robert Alexander Ingram is also on the board of H. Lee Moffitt Cancer Center & Research Institute, Inc., American Cancer Society Foundation (former Chairman), CEO Roundtable on Cancer, Inc. (former Chairman) and James B. Hunt, Jr. Institute for Educational Leadership & Poli and Chairman of GlaxoSmithKline Foundation, Chairman at North Carolina Glaxosmithkline Foundation, Member-Governors Board at Research Triangle Institute and Member of Business-Higher Education Forum.

In his past career he was Chairman for Wolfspeed, Inc., Independent Director at Novan, Inc., Chairman at Serenity Pharmaceuticals Corp., Chairman for Bausch Health Cos., Inc., Director at Lowe's Cos., Inc., Non-Executive Chairman for Elan Corp. Plc, Chairman of OSI Pharmaceuticals, Inc., Chairman & Chief Executive Officer for Glaxo Wellcome Plc, Chairman for Elan Pharmaceuticals, LLC, Chairman, President & Chief Executive Officer at Glaxo Wellcome, Inc., Chairman at Glaxo, Inc., President at Merck Frosst Canada Ltd., Vice Chairman-Pharmaceuticals at GlaxoSmithKline LLC, Principal at National Institutes of Health, Vice President-Public Affairs at Merrell Dow Pharmaceuticals, Inc. and Chairman at American Foundation for Pharmaceutical Education.

Mr. Ingram received an undergraduate degree from Eastern Illinois University.


Posities en verantwoordelijkheden van Robert Alexander Ingram 
NaamTitel Van
BioCryst Pharmaceuticals, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman 2017
Black Diamond Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman 2020
Viamet Pharmaceuticals, Inc. Chairman -
Viamet Pharmaceuticals Corp. Chairman 2014
Research Triangle Foundation Chairman -
GlaxoSmithKline Foundation Chairman -
North Carolina Glaxosmithkline Foundation Chairman -
H. Lee Moffitt Cancer Center & Research Institute, Inc. Director -
American Cancer Society Foundation Vice Chairman 2009
CEO Roundtable on Cancer, Inc. Director -
James B. Hunt, Jr. Institute for Educational Leadership & Poli Director -
Research Triangle Institute Member-Governors Board -
Business-Higher Education Forum Member -
Hatteras Venture Partners General Partner -


Belangnemingen van Robert Alexander Ingram 
NaamAandelen%Totale waarde
BioCryst Pharmaceuticals, Inc. (BCRX)
(Biotechnologie & Medisch Onderzoek)
96 4420,052%1 340 544 USD
Black Diamond Therapeutics, Inc. (BDTX)
(Biotechnologie & Medisch Onderzoek)
33 4790,092%106 798 USD


Robert Alexander IngramPersoonlijk netwerk 
Meest gelezen nieuws 
29/09Buffett's Berkshire Hathaway koopt 5,99 mln extra aandelen Occidental
MR
26/09De soap van Unilever: Fusies en overnames, banenreducties, Nelson Peltz in de raad van bestuur
MR
20/09JPMorgan CEO Dimon waarschuwt Congres voor economische 'stormwolken' - getuigenis
MR
26/09Twitter interviewt Elon Musk, bekend om strijdlustige getuigenissen
MR
21/09Het proces tegen Trump-bondgenoot Barrack op beschuldiging van buitenlandse agent begint met openingsverklaringen
MR
20/09Palihapitiya gaat twee blanco cheques afbouwen nu wankele markten waarderingen afremmen
MR
29/09De lange, bochtige weg naar de beursgang van Volkswagen's Porsche
MR
21/09Bloomberg trekt 85 miljoen dollar uit tegen uitbreiding plastic en petrochemie in de VS
MR
28/09Elon Musk wil toestemmingsovereenkomst SEC versmallen, einde aan voorafgaande goedkeuring van tweets
MR
15/09Elon Musk beschuldigt Twitter van veiligheidslekken in rechtszaak
MR
Meer nieuws


© 2022 People and Ownership :   
Robert Alexander Ingram Verbindingen